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INTRODUCTION
Closed-suction drains are widely used in breast reconstruction. 
These drains are removed according to a volume-based criteri-
on, which is typically defined as < 30 mL/day [1,2]. Although 
the specific volume criterion used may vary, the general princi-
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ple is to remove the drain when the drainage volume produced 
over time decreases. A higher drainage volume results in a lon-
ger duration of drain placement and postoperative disruption to 
patients’ lives. In general, antibiotics are administered as long as 
a drain remains in place. Depending on the physician’s prefer-
ence, patients may also be restricted with regard to showering 
while they have drains in place [1]. Some studies also suggest 
that longer drainage times increase the risk of surgical-site infec-
tions [3-5]. For these reasons, it is of crucial importance for 
plastic surgeons to be able to predict drainage volume after 
breast reconstruction.
Several factors may influence postoperative drainage volume. 
These include patient-related factors (such as obesity and medi-
cal history) and operative factors (such as operative time and 
surgical instruments used) [6]. In expander-based breast recon-
struction, the expander type (smooth or textured), the surgical 
instrument type, and the type of acellular dermal matrix (ADM) 
may also influence the drainage volume. One study showed that 
older age, larger breast mass, and axillary lymph node dissection 
status affected drainage volume [6]. Another study suggested 
that ADM use was associated with increased drainage and that 
older age, a larger expander, and a larger drainage volume on the 
first postoperative day were predictors of a longer time to drain 
removal [7]. Nonetheless, few studies have analyzed factors that 
predict drainage volume after breast reconstruction procedures. 
In this study, patients’ daily drainage volume following expand-
er-based breast reconstruction was retrospectively reviewed. 
Additionally, we explored factors that were associated with 
drainage volume through univariate and multivariate analyses.
METHODS
Patients
All female patients who underwent expander-based breast re-
construction immediately after mastectomy between April 2014 
and January 2018 were retrospectively analyzed. A total of 165 
patients were reviewed. Six patients were excluded from the 
data: one patient with postoperative hematoma, one with post-
operative seroma, and four due to a lack of data. After this exclu-
sion, 159 patients and 176 expanders were analyzed. The pa-
tient characteristics are shown in Table 1, and the operative fac-
tors are summarized in Table 2.
Operative technique
One of three mastectomy techniques was performed: total mas-
tectomy with skin and nipple resection, skin-sparing mastecto-
my with only nipple resection, and nipple-sparing mastectomy. 
These types of mastectomies were classified into either mastec-
tomy with skin excision or mastectomy without skin excision. 
An expander was always used when the skin was removed. Be-
cause of the high rate of nipple necrosis in our hospital, two-
stage breast reconstruction using an expander is our facility’s de-
fault procedure, especially in the cases of patients who request 
contralateral side breast augmentation. Two types of expanders, 
the Mentor CPX4 expander (Mentor Worldwide LLC, Irvine, 
CA, USA) and the Natrelle expander (Allergan PLC, Dublin, 
Ireland) were used. The type of expander was selected based on 
Variable Value
No. of patients 159
No. of expanders 176
Sex
  Male 0
  Female 159 (100)
Age at initial operation (yr) 44.17±9.15
Height (cm) 160.77±5.22
Body weight (kg) 58.63±15.40
Body mass index (kg/m²) 22.64±5.47
History
  Smoking 7 (3.98)
  Diabetes 6 (3.40)
  Neoadjuvant chemotherapy 26 (14.77)
  Neoadjuvant radiotherapy 3 (1.70)
Total drainage volume (mL) 1,242.08±640.20
Duration of drain placement (day) 15.48±6.18
Values are presented as number (%) or mean±SD.
Table 1. Patient characteristics
Variable Value
Type of mastectomy
  Nipple-sparing mastectomy 87 (49.4)
  Mastectomy with skin excision 89 (50.6)
Specimen weight (g) 399.89±206.72
Axillary lymph node dissection 39 (22.15)
Tissue expander type
  Allergan 142 (80.68)
  Mentor  34 (19.32)
Tissue expander volume (mL) 456.30±85.46
  Allergan 489.06±63.16
  Mentor 449.03±88.20
Intraoperative inflation volume (mL) 99.74±36.50
Acellular dermal matrix type
  MegaDerm 48 (27.27)
  CGCryoDerm 115 (65.34)
  DermACELL 10 (5.68)
  AlloDerm 3 (1.70)
Surgical instrument
  Monopolar coagulator 155 (88.07)
  Harmonic scalpel  21 (11.93)
Values are presented as number (%) or mean±SD.
Table 2. Operative factors
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the surgeon’s criteria. The width of the chest was the first condi-
tion to be considered. After determining the width of the ex-
pander, we chose the volume of the expander to achieve the de-
sired breast size. When the patient requested augmentation of 
the contralateral breast, we selected a high-profile expander cor-
responding to the target volume. When the patient did not re-
quest a contralateral procedure, we selected an expander corre-
sponding to the contralateral breast volume. The expander was 
placed in the submuscular pocket. The ADM was sutured to the 
inferolateral border of the pectoralis major muscle and was used 
to cover the expander. A closed drain was placed in the inframa-
mmary fold area, while another was placed in the axillary space. 
Four types of non-washed, non-frozen ADMs without slit inci-
sions were used: MegaDerm (6 × 16 cm, 1.5 mm thickness; 
L&C Bio Corp., Seoul, Korea), CGCryoDerm (6 × 16 cm, 1–2 
mm thickness; CG Bio, Seongnam, Korea), DermACELL 
(6 × 16 cm, 1–2 mm thickness; LifeNet Health, Virginia Beach, 
VA, USA), and AlloDerm (4 × 12 cm, 2.3–3.3 mm thickness; 
LifeCell Corp., The Woodlands, TX, USA). Two surgical in-
struments were used to elevate the pectoralis muscle and to 
control intraoperative bleeding: a monopolar coagulator, Surgi-
Stat II (Valleylab, Boulder, CO, USA), and an ultrasound surgi-
cal device, the Harmonic scalpel (Ethicon Endo-Surgery, Cin-
cinnati, OH, USA).
Postoperative management
Patients were treated with two antibiotics (cephalosporin, 2 g/
day and aminoglycoside, 400 mg/day) until the final drain was 
removed. The drainage volume was checked every day until the 
removal of the drain. Each drain was removed when its output 
was < 30 mL/day. The duration of drain placement was record-
ed based on the date when the last drain was removed. The total 
drainage volume was calculated as the sum of the volumes of 
both drains.
Statistical analysis
All analyses were performed using SPSS version 23.0 (IBM 
Corp., Armonk, NY, USA). Data are expressed as the mean ±  
standard deviation. P-values < 0.05 were considered to indicate 
statistical significance. Univariate analyses were performed with 
each variable. Linear regression was performed between the to-
tal drainage volume and each factor as a continuous variable. 
The B-value refers to how much the dependent variable changes 
when the independent variable is changed by a 1-unit incre-
ment. Comparisons between the two groups were performed 
using the independent t-test, and comparisons among the four 
groups were performed using analysis of variance. Factors that 
showed significant results in univariate analysis were analyzed 
with multivariate multiple regression analysis. The variance in-
flation factor was calculated to confirm multicollinearity. 
RESULTS
The total drainage volume gradually decreased postoperatively 
(Fig. 1). The trend for the daily drainage volume over time 
showed a similar pattern for each expander, but on each postop-
erative day, patients with Mentor expanders showed more drain-
age than those with Allergan expanders (Fig. 2). The average 
duration of drain placement was 15.48 ± 6.18 days, the total 
drainage was 1,242.08 ± 640.20 mL, and the two were strongly 
Fig. 1. Daily drainage volume over time
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Fig. 2. Daily drainage difference between Allergan and Mentor 
expanders
Comparison of daily drainage volume over time between patients 
with Allergan and Mentor expanders. Drainage volume was calcu-
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correlated (P < 0.001, correlation coefficient = 0.892). No statis-
tically significant difference (P = 0.086) was found between tis-
sue expander volume according to the type of expander (Men-
tor expanders, 449.03 ± 88.20 mL; Allergan expanders, 489.06 ±  
63.16 mL) (Table 2).
The results of the univariate analysis of patient factors are sum-
marized in Tables 3 and 4. Age (P < 0.001, B = 0.165) was 
strongly correlated with total drainage volume. In contrast, 
height was not associated with total drainage volume (P = 0.55). 
Body weight (P < 0.001, B = 17.758) and body mass index 
(BMI) (P < 0.001, B = 51.817) were strongly correlated with to-
tal drainage volume. Patients with diabetes produced a total of 
2,131.77 ± 851.25 mL of drainage, while those without diabetes 
produced 1,210.67 ± 611.45 mL (P < 0.001). In contrast, smok-
ing did not have a significant effect on total drainage volume 
(P = 0.696). Patients who received neoadjuvant chemotherapy 
tended to have a higher total drainage volume than those who 
did not, although the difference was not significant (P = 0.135). 
In contrast, neoadjuvant radiotherapy did not affect the total 
drainage (P = 0.496).
The results of the univariate analysis of operative factors are 
summarized in Tables 5 and 6. The specimen weight, which was 
measured immediately after mastectomy, was strongly correlated 
with the total drainage volume (P < 0.001, B = 1.590). Other op-
Factor B-value Standard error P-value
Patient factors and total drainage volume
  Age (yr) 19.825 5.088 <0.001
  Height (cm) 5.634 9.279 0.550
  Body weight (kg) 17.758 2.849 <0.001
  Body mass index (kg/m²) 51.817 7.947 <0.001
Patient factors and duration of drain placement
  Age (yr) 0.165 0.050 <0.001
  Height (cm) 0.084 0.089 0.347
  Body weight (kg) 0.160 0.028 <0.001
  Body mass index (kg/m²) 0.455 0.078 <0.001
Factor Yes No P-value
Patient factors and total drainage volume (mL)
  Diabetes 2,131.77±851.25 1,210.67±611.45 <0.001
  Smoking 1,149.14±493.55 1,245.92±646.42 0.696
  Neoadjuvant chemotherapy 1,415.58±688.33 1,212.00±629.06 0.135
  Neoadjuvant radiotherapy 991.66±192.25 1,246.41±644.56 0.496
Patient factors and duration of drain placement (day)
  Diabetes 22.83±8.13 15.22±5.96 0.003
  Smoking 13.86±5.64 15.55±6.20 0.479
  Neoadjuvant chemotherapy 16.23±5.47 15.45±6.30 0.505
  Neoadjuvant radiotherapy 14.67±3.79 15.50±6.22 0.818
Values are presented as mean±SD.
Factor B-value Standard error P-value
Operative factors and total drainage volume
  Specimen weight 1.590 0.208 <0.001
  Tissue expander volume 2.949 0.522 <0.001
  Intraoperative inflation volume 6.081 1.247 <0.001
Operative factors and duration of drain placement
  Specimen weight 0.012 0.002 <0.001
  Tissue expander volume 0.025 0.005 <0.001
  Intraoperative inflation volume 0.049 0.012 <0.001
Table 3. Linear regression analysis of patient factors
Table 4. Comparison between groups by patient factors
Table 5. Linear regression analysis of operative factors
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erative factors, including the tissue expander volume (P < 0.001, 
B = 2.949) and the intraoperative inflation volume (P < 0.001, 
B = 6.081), were also strongly correlated with the total drainage. 
The mastectomy type (mastectomy with skin excision vs. mas-
tectomy without skin excision) did not affect the total drainage 
(P = 0.756). Axillary lymph node dissection was associated with 
a higher total drainage volume, but this relationship was also not 
statistically significant (P = 0.288). There were significant differ-
ences in the total drainage volume depending on the tissue ex-
pander type (Allergan, 1,098.72 ± 527.37 mL; Mentor, 1,840 ±  
726.21 mL; P < 0.001). Use of the Mentor expander led to a 
higher volume of total drainage and a longer duration of drain 
placement. The type of surgical instrument used had a signifi-
cant effect on the total drainage volume (monopolar coagulator, 
1,186 ± 604.73 mL; Harmonic scalpel, 1,650.19 ±  756.13 mL; 
P = 0.002). In its relationships with these factors, the duration of 
drain placement showed largely similar tendencies as the total 
drainage volume. 
There were slight differences in the total drainage volume and 
the duration of drain placement according to the type of ADM 
used (MegaDerm, CGCryoDerm, DermACELL, or AlloDerm), 
but these differences were not statistically significant (analysis 
Factor Yes No P-value
Operative factors and total drainage volume (mL)
  Type of mastectomy (skin excision) 1,227.20±699.89 1,257.29±576.45 0.756
  Axillary lymph node dissection 1,338.38±497.71 1,214.66±674.35 0.288
  Tissue expander typea) 1,098.72±527.37 1,840.80±726.21 <0.001
  Surgical instrumentb) 1,186.78±604.73 1,650.19±756.13 0.002
Operative factors and duration of drain placement (day)
  Comparison between groups 
  Type of mastectomy (skin excision) 15.37±6.91 15.60±5.36 0.808
  Axillary lymph node dissection 15.41±4.99 15.50±6.49 0.934
  Tissue expander typea) 13.95±4.77 21.88±7.26 <0.001
  Surgical instrumentb) 15.06±6.15 18.62±5.57 0.013
Values are presented as mean±SD.
a)Tissue expander type: Yes indicates Allergan, No indicates Mentor; b)Surgical instrument: Yes indicates monopolar coagulator, No indicates Harmonic scalpel.
Table 6. Comparison between groups by operative factors
Drainage volume (mL) Duration of drain placement (day)
Average Standard error P-value Average Standard error P-value
Type 0.626 0.350
  MegaDerm 1,147.046 87.487 14.688 0.873
  CGCryoDerm 1,282.656 61.776 15.513 0.565
  DermACELL 1,281.860 177.786 17.900 2.193
  AlloDerm 1,074.333 378.080 19.000 6.000
Table 7. Analysis of variance between types of acellular dermal matrix
Factor B-value SE P-value VIF
Age 11.907 4.078 0.004 1.068
Body weight 3.051 2.787 0.148 1.430
Specimen weight 0.927 0.225 <0.001 1.640
Tissue expander volume 0.726 0.517 0.162 1.495
Diabetes 308.479 210.054 0.144 1.151
Tissue expander type 593.728 97.970 <0.001 1.122
Energy device 146.243 117.745 0.216 1.149
SE, standard error; VIF, variance inflation factor.
Statistically significant factors are shown in age, specimen weight, and tissue 
expander type.
Table 8. Multiple regression analysis of factors related to 
total drainage volume
Factor B-value SE P-value VIF
Age 0.106 0.041 0.010 1.068
Body weight 0.044 0.028 0.120 1.430
Specimen weight 0.006 0.002 0.013 1.640
Tissue expander volume 0.008 0.005 0.149 1.495
Diabetes 2.492 2.110 0.239 1.151
Tissue expander type 6.789 0.984 0.000 1.122
Energy device 0.298 1.183 0.801 1.149
SE, standard error; VIF, variance inflation factor.
Statistically significant factors are shown in age, specimen weight, and tissue 
expander type.
Table 9. Multiple regression analysis of factors related to 
duration of drain placement 
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of variance, P = 0.626 and P = 0.350 for total drainage and dura-
tion of drain placement, respectively) (Table 7).
In the multiple regression analyses (adjusted R2, 0.466), age 
(P = 0.004, B = 11.907), specimen weight (P < 0.001, B = 0.927), 
and tissue expander type (P < 0.001, B = 593.728) were signifi-
cantly related to the total drainage volume. Moreover, age (P =  
0.010, B = 0.106), specimen weight (P = 0.013, B = 0.006), and 
tissue expander type (P < 0.001, B = 6.789) were significantly 
related to the duration of drain placement (Tables 8 and 9). Pa-
tients who were older, had heavier specimen weights, and un-
derwent surgery using an Allergan expander rather than a Men-
tor expander showed a greater volume of total drainage and a 
longer duration of drain placement. BMI was significant in the 
univariate linear regression, but it was excluded from the multi-




It is critical to manage drainage volume after breast reconstruc-
tion surgery to prevent complications such as seroma and infec-
tion. A randomized study found that closed-suction drainage 
decreased the incidence and degree of seroma formation [8]. 
Another study found that a drainage flow rate > 50 mL/day was 
associated with seroma formation postoperatively [9]. Most 
plastic surgeons use closed-suction drains after breast recon-
struction and remove them when the drain output is < 30 mL/
day [1,2], and we used the same criterion in this study. Only 
one patient in our study developed a seroma, and the case was 
excluded from the data. Because a drainage volume exceeding 
the drain removal standard had continued for more than 6 
weeks, the two drains—the drain placed under the inframam-
mary area and the drain placed under the axilla—were not ana-
lyzed separately. The total drainage volume and the date of re-
moval of the last drain were recorded.
Age was strongly correlated with the total drainage volume in 
both univariate and multivariate analyses (P < 0.001 and P =  
0.004, respectively). A prior study also reported the same result, 
in that older patients had a higher drainage volume than young-
er patients [6]. Previous studies of autologous breast recon-
struction have found advanced age ( > 45 years in one study 
[10] and > 65 years in another study [11]) to be a risk factor for 
seroma formation. Other complications, such as surgical site in-
fection [3] and venous thromboembolism [12], have also been 
reported more frequently after breast surgery in patients of ad-
vanced age than in younger patients.
 Specimen weight was strongly correlated with total drainage 
volume in both univariate and multivariate analyses (P < 0.001 
and P < 0.001, respectively). In the univariate analysis, body 
weight, mastectomy specimen weight, and BMI were correlated 
with the total drainage volume, but the multivariate analysis did 
not find a significant relationship for body weight, mastectomy 
specimen weight, and BMI. This could have been due to the 
confounding effect of patients with a higher body weight and 
BMI having a higher specimen weight. These results suggest 
that breast mass has a major influence on the total drainage vol-
ume after expander-based breast reconstruction, as was previ-
ously reported by Suga et al. [6]. The impact of breast mass on 
outcomes of breast reconstruction have been studied extensive-
ly. Woerdeman et al. [13] reported a significantly higher fre-
quency of implant loss in breasts that were larger than average. 
Duggal et al. [14] found that postoperative wound infections 
were more common in patients with larger breasts. Further-
more, Wang et al. [15] demonstrated an association of larger 
breast mass with an elevated risk of superficial nipple necrosis 
after nipple-sparing mastectomy. In a study of expander-based 
breast reconstruction procedures, Francis et al. [16] reported 
that a breast size larger than a C cup was a risk factor for infec-
tion. Therefore, patients with large breasts should be informed 
that they are likely to have a longer duration of drain placement 
and a higher drainage volume than women with smaller breasts 
(Tables 5, 6, 8, 9).
The tissue expander type was found to have a significant influ-
ence on the total drainage volume after expander-based breast 
reconstruction in both univariate and multivariate analyses 
(P < 0.001). The group that underwent surgery using the Men-
tor expander had a higher drainage volume (by approximately 
750 mL) than those who underwent surgery using the Allergan 
expander. This extra volume corresponded to 8 additional days 
of drainage (Table 6). We used two types of expander, which are 
manufactured in different ways. The Allergan expander is creat-
ed using the lost-salt technique, while the Mentor expander is 
generated using a pressure imprint-stamping technique [17]. 
The major difference between the two expanders comes from 
their surfaces. In a recent study, the Allergan implant displayed a 
larger external surface area per unit of internal surface area than 
the Mentor implant under microscopy [17]. According to the 
classification system used by that study, the Allergan implant has 
a macrotextured surface (200–300 mm2), and the Mentor im-
plant has a microtextured surface (100–200 mm2) [17]. There-
fore, we can hypothesize that the difference in surface texturing 
may relate to the difference in drainage volume. As the number 
of Mentor expanders used in this study was lower than the num-
ber of Allergan expanders (Allergan 142, Mentor 34), it is pre-
mature to conclude that the use of a certain implant leads to a 
greater drainage volume. Nevertheless, this paper is meaningful 
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in that it shows that there may be a difference in drainage vol-
ume depending on the surface type of the implant. The surgeon 
should be aware of the possibility of the difference in postopera-
tive drainage volume depending on the type of implant. Howev-
er, further research is needed, as there has been no previous re-
search on this topic.
Recently, breast implant-associated anaplastic large-cell lym-
phoma (BIA-ALCL) has become an issue in the use of breast 
implants. Although the pathophysiology of BIA-ALCL is un-
clear, a recent report published by the U.S. Food and Drug Ad-
ministration showed that BIA-ALCL occurs mainly in patients 
for whom textured implants were used [18]. Disease-specific 
risks are reported depending on the manufacturer and the im-
plant surface type [19]. The cause of BIA-ALCL is not yet 
clearly understood. Therefore, multifaceted measurements and 
analyses of the effect of the implant surface on the human body 
may help determine the cause of BIA-ALCL. As one of the main 
symptoms of BIA-ALCL is fluid collection around the implant, 
it is expected that further studies of the relationship between 
BIA-ALCL and drainage volume will be of interest and will shed 
light onto basic aspects of BIA-ALCL.
 Patients with diabetes also demonstrated significantly greater 
drainage volumes than those without diabetes in the univariate 
analysis (P < 0.001). However, this relationship was not signifi-
cant in the multivariate analysis (P = 0.144). Of the six patients 
with diabetes, one patient was treated with insulin injections, 
and the other five patients were treated with oral medication. 
One patient treated with oral medication had normal glucose 
levels at the day of surgery. In contrast, another study found that 
a history of diabetes did not impact total drainage [6]. However, 
that study included only one patient with diabetes, while our 
study included six patients with diabetes (3.4%). Therefore, 
more data are needed to clarify these discrepant results.
Patients who were treated with neoadjuvant chemotherapy 
demonstrated a higher total volume of drainage than those who 
did not receive neoadjuvant chemotherapy, although the differ-
ence was not statistically significant. However, this result may be 
confounded by whether the patient underwent axillary lymph 
node dissection. Another study showed that neoadjuvant che-
motherapy alone had no effect on total drainage volume [6]. 
Other studies have reported that neoadjuvant chemotherapy 
did not increase the complication rate after immediate breast re-
construction [20,21]. 
Patients who underwent axillary lymph node dissection had 
higher total drainage volumes than those who did not, although 
the difference was not statistically significant (P = 0.288). A pre-
vious study found that axillary lymph node dissection status had 
a significant influence on total drainage volume following ex-
pander-based breast reconstruction procedures [6]. Another 
study compared short-term and long-term drainage after mas-
tectomy with axillary dissection, and reported a higher inci-
dence of seroma in the short-term drainage group [22]. Fur-
thermore, another study demonstrated an association of axillary 
dissection with an elevated risk of implant loss in prosthetic 
breast reconstruction procedures [23]. Therefore, patients who 
undergo axillary lymph node dissection must be monitored 
carefully during postoperative management. One effective tech-
nique to assess the impact of axillary lymph node dissection 
would be to measure the amount of drainage from drains insert-
ed into the axillary area independently from other drains insert-
ed elsewhere. Therefore, the fact that the axillary and inframam-
mary drains were not measured separately is a limitation of this 
study.
Tissue expander volume and intraoperative inflation volume 
were both strongly correlated with total drainage volume in the 
univariate analysis (P < 0.001). However, this relationship was 
not significant in the multivariate analysis (P = 0.149). This re-
sult, however, may have been confounded by the specimen 
weight, because larger specimens require larger tissue expanders 
and more intraoperative inflation. With this in mind, when 
comparing results within the same tissue expander size, no sig-
nificant difference was found in the drainage volume based on 
intraoperative inflation volume. 
Interestingly, the type of surgical instrument used had a signifi-
cant influence on the drainage volume in the univariate analysis 
(P = 0.013). However, this relationship was not significant in 
the multivariate analysis (P = 0.216). Patients who underwent 
surgery using a Harmonic scalpel produced a significantly high-
er total drainage volume than those who were operated on using 
a monopolar coagulator. The precise mechanism by which the 
surgical instruments affect the drainage volume requires further 
investigation. In addition, the effectiveness of a surgical instru-
ment is greatly influenced by the method and duration of the 
operation. However, this study did not measure the operation 
duration or specify the exact operation method. Regardless, sur-
geons should be aware that there might be differences in drain-
age volume depending on their choice of surgical instrument.
There were no significant differences between the four types 
of ADM (MegaDerm, CGCryoDerm, DermACELL, and Allo-
Derm) with regard to drainage volume or duration of drain 
placement. This may be meaningful, as no prior studies have ad-
dressed this issue. Although there was a difference in the size or 
thickness of the ADMs used, this difference was not statistically 
significant.
Similar studies have been performed in the past, but our study 
is meaningful in that it examined a large number of patients. A 
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previous study showed that age, breast mass, and axillary lymph 
node dissection status are important factors for predicting the 
total drainage and duration of drain placement [6]. Our study 
produced similar conclusions in that age and specimen weight 
were important predictors. Interestingly, the present study also 
found that the type of expander had a significant effect on the 
amount of drainage. 
Despite these strengths, this study was limited by selection 
bias. Patients with known risk factors, such as a history of smok-
ing or diabetes, may have been discouraged from undergoing 
breast reconstruction. Although criteria for expander selection 
were specified, surgeons may have suffered from selection bias 
in the expander selection process. Another limitation of this 
study is that we did not distinguish between the axillary and in-
framammary drains with regard to drainage volume. If we had 
measured the drainage volume of each drain separately, we 
would have been able to assess the effect of axillary lymph node 
dissection. The fact that this study was performed by a single 
surgeon has both advantages and disadvantages. It is effective to 
compare variables that are not influenced by surgeon-related 
factors, but it is ineffective to compare variables that are influ-
enced by operative skill, like surgical instrument usage. 
Surgeons can better predict the total drainage and duration of 
drain placement after expander-based breast reconstruction 
based on preoperative and intraoperative information. For in-
stance, the patient’s age, specimen weight, and expander type 
used were important factors for predicting drainage volume in 
this study. In contrast, the drainage volume was not affected by 
the patient’s height, smoking history, neoadjuvant chemothera-
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